Search results for " Geriatrics"

showing 10 items of 158 documents

Aspirin and incident depressive symptoms: A longitudinal cohort study over 8 years

2017

Objective: Aspirin exhibits anti-atherosclerotic and anti-inflammatory properties—two potential risk factors for depression. The relationship between aspirin use and depression, however, remains unclear. We investigated whether the aspirin use is associated with a decreased incidence of depressive symptoms in a large North American cohort. Methods: Data from the Osteoarthritis Initiative dataset, a multicenter, longitudinal study on community-dwelling adults was analyzed. Aspirin use was defined through self-report in the past 30 days and confirmed by a trained interviewer. Incident depressive symptoms were defined as a score of ≥16 in the 20-item Center for Epidemiologic Studies-Depression…

Malemedicine.medical_specialtyLongitudinal studyEpidemiologyAspirin; Cohort; Depression; Epidemiology; Psychiatry; Survey; Geriatrics and Gerontology; Psychiatry and Mental Healthaspirin cohort depression epidemiology psychiatry surveyArticle03 medical and health sciences0302 clinical medicine*aspirinFibrinolytic AgentsInternal medicineMedicineHumansLongitudinal Studies*epidemiologySurveyAgedProportional Hazards Models*surveyPsychiatryAspirinDepressive Disorder*cohortAspirinbusiness.industryProportional hazards modelDepressionIncidence (epidemiology)IncidenceHazard ratioAnti-Inflammatory Agents Non-SteroidalCohortMiddle Aged030227 psychiatryPsychiatry and Mental Health*psychiatryCohortPropensity score matchingPhysical therapyRegression AnalysisFemaleGeriatrics and Gerontologybusiness*depression030217 neurology & neurosurgeryFibrinolytic agentmedicine.drug
researchProduct

A Follow-Up Study of a Reminiscence Intervention and Its Effects on Depressed Mood, Life Satisfaction, and Well-Being in the Elderly

2017

The purpose of this study was to investigate the extent to which a reminiscence intervention reduces depressed mood and improves life satisfaction and psychological well-being. 160 healthy elderly people participated in a 10-session intervention. An experimental design with pretest and posttest evaluations was applied, comparing a control group to an intervention group to evaluate the effects of the program. Follow-up measures were also taken to find out whether the intervention's positive effects lasted over time. Mixed Model ANOVAs showed significant increases in the time-group interaction, life satisfaction, and psychological well-being measures, and decreases in depressed mood, after tr…

Malemedicine.medical_specialtyMemory Episodic050109 social psychologyPersonal SatisfactionEducation03 medical and health sciences0302 clinical medicineQuality of lifeIntervention (counseling)ReminiscencemedicineHumans0501 psychology and cognitive sciencesPsychiatryGeneral PsychologyAgedAnalysis of Variance030214 geriatricsDepressionDominican Republic05 social sciencesFollow up studiesLife satisfactionHealthy elderlyWell-beingQuality of LifeBusiness Management and Accounting (miscellaneous)FemaleDepressed moodPsychologyFollow-Up StudiesClinical psychologyThe Journal of Psychology
researchProduct

Osteoarthritis Increases the Risk of Cardiovascular Disease: Data from the Osteoarthritis Initiative

2018

Objectives: Although osteoarthritis (OA) is a common condition in older adults, the role of OA in increasing cardiovascular disease (CVD) incidence is still debated. The aim of this study was to investigate the association between OA and the onset of CVD in a large database of American adults. Design: Longitudinal. Setting: Community-dwelling. Participants: People with OA or at high risk of OA. Measurements: Osteoarthritis was defined as the presence of OA of the hand, knee, hip, back/neck or of other sites. CVD was defined as self-reported presence of heart attack, heart failure, stroke and other cerebral atherosclerotic conditions, and peripheral artery disease. Results: A total 4,265 per…

Malemedicine.medical_specialtyMyocardial InfarctionMedicine (miscellaneous)OsteoarthritisDiseaseOsteoarthritis HipPeripheral Arterial Disease03 medical and health sciences0302 clinical medicineRisk Factorscardiovascular diseaseInternal medicineOsteoarthritisEpidemiologymedicineHumansOsteoarthritis cardiovascular disease epidemiologyLongitudinal StudiesObesity030212 general & internal medicinecardiovascular disease; epidemiology; Osteoarthritis; Medicine (miscellaneous); Nutrition and Dietetics; Geriatrics and GerontologyStrokeAgedProportional Hazards ModelsHeart Failure030203 arthritis & rheumatologyNutrition and Dieteticsbusiness.industryIncidence (epidemiology)ConfoundingHazard ratioMiddle AgedOsteoarthritis Kneemedicine.diseaseStrokeCardiovascular DiseasesHeart failurePhysical therapyFemaleOsteoarthritis SpineepidemiologyIndependent LivingGeriatrics and Gerontologybusiness
researchProduct

Prescription of anti-osteoporosis medications after hospitalization for hip fracture: a multicentre Italian survey.

2017

Purpose: Literature data indicate that the proportion of patients with recent hip fracture who receive a prescription for anti-osteoporotic drugs is low and does not seem to increase over time. This study aimed to obtain data on the prescription for anti-osteoporotic drugs in Italian patients discharged after a recent hip fracture and to assess which variables could have influenced the decision for prescribing osteoporosis medication. Methods: A total of four Italian centres located in four different geographical areas (Siena, Verona, Naples and Palermo) participated in this retrospective study. In each centre, experienced clinicians gathered the data of up to 200 consecutive patients disch…

Malemedicine.medical_specialtyPediatricsHip fracture; Anti-osteoporotic drugs; Comorbidities; Ca/vitamin D supplementsAgingAnti-osteoporotic drugs; Ca/vitamin D supplements; Comorbidities; Hip fractureAnti-osteoporotic drugOsteoporosisAlternative medicine030209 endocrinology & metabolismComorbiditiesHip fracture03 medical and health sciences0302 clinical medicineSex FactorsSurveys and QuestionnairesmedicineHumans030212 general & internal medicineMedical prescriptionPractice Patterns Physicians'AgedRetrospective StudiesAged 80 and overHip fractureBone Density Conservation AgentsGeriatrics gerontologybusiness.industryHip FracturesSettore MED/34 - Medicina Fisica E RiabilitativaRetrospective cohort studyMean ageMiddle Agedmedicine.diseaseCa/vitamin D supplementsHospitalizationAnti-osteoporotic drugsItalyAnti osteoporosisPhysical therapyAnti-osteoporotic drugs; Ca/vitamin D supplements; Comorbidities; Hip fracture; Aging; Geriatrics and GerontologyOsteoporosisFemaleCa/vitamin D supplementComorbiditieGeriatrics and GerontologybusinessOsteoporotic FracturesAging clinical and experimental research
researchProduct

Acetylcholinesterase inhibitors are associated with weight loss in older people with dementia: A systematic review and meta-analysis

2016

We conducted a systematic review and meta-analysis investigating the influence of acetylcholinesterase inhibitors (AChEIs) therapy on nutritional status and weight across observational and interventional studies. Two authors searched major electronic databases from inception until 10/14/2015 for longitudinal, open-label and randomised double-blind placebo controlled (randomised controlled trials (RCTs)) studies of AChEIs in patients with dementia reporting nutritional status outcome data. Out of 3551 initial hits, 25 studies (12 open-label trials, 9 RCTs and 4 longitudinal studies) including 10 792 patients with dementia were meta-analysed. In longitudinal studies (median follow-up 6 months…

Malemedicine.medical_specialtyPlaceboRisk Assessment03 medical and health sciences0302 clinical medicineArts and Humanities (miscellaneous)Weight lossAlzheimer DiseaseInternal medicineWeight LossmedicineDementiaHumansCumulative incidence030212 general & internal medicineAgedRandomized Controlled Trials as TopicGeriatricsbusiness.industryDEMENTIAmedicine.diseaseMETA-ANALYSISALZHEIMER'S DISEASE; DEMENTIA; GERIATRICS; META-ANALYSIS; Neurology (clinical); Psychiatry and Mental Health; Surgery; Arts and Humanities (miscellaneous)Acetylcholinesterase inhibitorsALZHEIMER'S DISEASEPsychiatry and Mental HealthMeta-analysisPhysical therapyObservational studyFemaleSurgeryCholinesterase InhibitorsNeurology (clinical)medicine.symptombusinessOlder peopleGERIATRICS030217 neurology & neurosurgery
researchProduct

Polypharmacy in older people: lessons from 10 years of experience with the REPOSI register

2018

As a consequence of population aging, we have witnessed in internal medicine hospital wards a progressive shift from a population of in-patients relatively young and mainly affected by a single ailment to one of ever older and more and more complex patients with multiple chronic diseases, followed as out-patients by many different specialists with poor integration and inevitably treated with multiple medications. Polypharmacy (defined as the chronic intake of five or more drugs) is associated with increased risks of drug-drug interactions and related adverse effects, prescription and intake errors, poor compliance, re-hospitalization and mortality. With this background, the Italian Society …

Malemedicine.medical_specialtyPopulation ageingDeprescribing; Inappropriate prescription; Medication reconciliation; Multimorbidity; PolypharmacyPopulationSocio-culturale030204 cardiovascular system & hematology03 medical and health sciences0302 clinical medicineDeprescribingRisk Factors80 and overDeprescribing; Inappropriate prescription; Medication reconciliation; Multimorbidity; Polypharmacy; Internal Medicine; Emergency MedicineInternal MedicinemedicineDeprescribing Inappropriate prescription Medication reconciliation Multimorbidity PolypharmacyHumansMultimorbidityRegistries030212 general & internal medicineMedical prescriptionAdverse effecteducationAgedAged 80 and overPolypharmacyGeriatricseducation.field_of_studybusiness.industryMultimorbidityPatient DischargeHospitalizationDeprescribing; Inappropriate prescription; Medication reconciliation; Multimorbidity; Polypharmacy; Aged; Aged 80 and over; Female; Geriatrics; Hospitalization; Humans; Italy; Male; Multimorbidity; Patient Discharge; Registries; Risk Factors; PolypharmacyItalyGeriatricsFamily medicinePolypharmacyEmergency MedicineMedication reconciliationFemaleDeprescribingbusinessDeprescribing; Inappropriate prescription; Medication reconciliation; Multimorbidity; Polypharmacy;Inappropriate prescriptionInternal and Emergency Medicine
researchProduct

The effects of enzalutamide and abiraterone on skeletal related events and bone radiological progression free survival in castration resistant prosta…

2017

Two new drugs, the CYP17 inhibitor abiraterone acetate and the androgen receptor (AR) antagonist enzalutamide, have recently shown to prolong OS prior chemotherapy or in docetaxel treated mCRPC patients, using steroidal therapy or placebo as control group. Updated analyses underlined the role of these new agents on two prostate-specific endpoints as radiographic progression-free survival (rPFS) and time to first skeletal-related event (tSRE). On the basis of these reports, we made an indirect comparison between abiraterone and enzalutamide. We obtained a clinically but not significant difference favouring enzalutamide over abiraterone in terms of rPFS (HR 0.48, 95% CI 0.22–1.02). No signi…

Malemedicine.medical_specialtySettore MED/06 - Oncologia Medicamedicine.medical_treatmentUrologyAbiraterone AcetateBone NeoplasmsAbiraterone; Enzalutamide; mCRPC; rPFS; tSRE; Hematology; Oncology; Geriatrics and GerontologyPlaceboDisease-Free Survivallaw.invention03 medical and health scienceschemistry.chemical_compoundProstate cancer0302 clinical medicineRandomized controlled triallawNitrilesPhenylthiohydantoinEnzalutamideAndrogen Receptor AntagonistsMedicineEnzalutamideCytochrome P-450 Enzyme InhibitorsHumans030212 general & internal medicineProgression-free survivalAbirateronetSRERandomized Controlled Trials as TopicChemotherapybusiness.industryAbiraterone acetateHematologymCRPCmedicine.diseaseProstatic Neoplasms Castration-ResistantTreatment OutcomechemistryDocetaxelrPFSOncology030220 oncology & carcinogenesisBenzamidesDisease ProgressionGeriatrics and Gerontologybusinessmedicine.drugCritical reviews in oncology/hematology
researchProduct

Is high dose rate brachytherapy reliable and effective treatment for prostate cancer patients? A review of the literature.

2014

The intrinsic physical and radiobiological characteristics of High Dose Rate Brachytherapy (HDR-BT) are well suited to the treatment of prostate cancer. HDR-BT was initially used as a boost to external beam brachytherapy, but has subsequently been employed as the sole treatment, which is termed HDR monotherapy. This review summarizes the clinical outcomes and toxicity results of the principal studies and discusses the radiobiological basis supporting its use.

Malemedicine.medical_specialtymedicine.medical_treatmentBrachytherapyBrachytherapyProstate cancermedicineEffective treatmentHumansMedical physicsDose FractionationSalvage brachytherapySalvage TherapyProstate cancerbusiness.industryRadiobiologyProstatic NeoplasmsRadiotherapy DosageHDR-BTHematologymedicine.diseaseBrachytherapy boost; HDR-BT; High-dose rate brachytherapy; Prostate cancer; Radiobiology; Salvage brachytherapy; Dose Fractionation; Humans; Male; Prostatic Neoplasms; Salvage Therapy; Treatment Outcome; Brachytherapy; Radiotherapy Dosage; Hematology; Oncology; Geriatrics and GerontologyHigh-Dose Rate BrachytherapyBrachytherapy boostTreatment OutcomeOncologyRadiologyDose Fractionation RadiationGeriatrics and GerontologybusinessHigh-dose rate brachytherapySalvage brachytherapyCritical reviews in oncology/hematology
researchProduct

Optimism as a key to improving mental health in family caregivers of people living with Alzheimer’s disease

2020

Objective: The aim of the present work was to study the serial multiple mediating role of optimism, perceived social support and subjective burden in the relationship between objective burden and psychological distress in caregivers of people with Alzheimer´s Disease (AD).Method: One hundred and forty family caregivers of people living with AD were recruited from randomly selected Alzheimer Association Centres. They answered the General Health Questionnaire (GHQ), the Life Orientation Test-Revised (LOT-R), the Functional Social Support Questionnaire (DUKE.UNC), the Zarit Burden Interview (ZBI) and questions relating to gender, age and the amount of time spent on daily caregiving.Results: Re…

Mediation (statistics)media_common.quotation_subjectPsychological interventionDisease03 medical and health sciencesSocial support0302 clinical medicineOptimismCost of IllnessAlzheimer DiseaseHumansmedia_common030214 geriatricsFamily caregiversMental healthPsychiatry and Mental healthCross-Sectional StudiesMental HealthCaregiversGeriatrics and GerontologyPshychiatric Mental HealthGeneral Health QuestionnairePsychologyGerontology030217 neurology & neurosurgeryClinical psychologyAging & Mental Health
researchProduct

A time series study on the effects of heat on mortality and evaluation of heterogeneity into European and Eastern-Southern Mediterranean cities: resu…

2013

Background: The Mediterranean region is particularly vulnerable to the effect of summer temperature. Within the CIRCE project this time-series study aims to quantify for the first time the effect of summer temperature in Eastern-Southern Mediterranean cities and compared it with European cities around the Mediterranean basin, evaluating city characteristics that explain between-city heterogeneity. Methods: The city-specific effect of maximum apparent temperature (Tappmax) was assessed by Generalized Estimation Equations, assuming a linear threshold model. Then, city-specific estimates were included in a random effect meta-regression analysis to investigate the effect modification by several…

Mediterranean climateMaleMESH: Urban HealthHot TemperatureTime FactorsClimateHealth Toxicology and MutagenesisVulnerability010501 environmental sciences01 natural sciencesMediterranean BasinMESH: Regression AnalysisMESH: Cause of Death0302 clinical medicineAfrica NorthernMESH: ChildCause of Death11. Sustainability030212 general & internal medicineMediterranean regionSocioeconomicsChildMESH: Aged[SDV.EE]Life Sciences [q-bio]/Ecology environmentMiddle EastMESH: Middle AgedMESH: Infant Newborn1. No povertyAge FactorsMiddle AgedMESH: ClimateMESH: Middle East/epidemiologyMESH: Infant3. Good healthGeographyMESH: Young AdultChild Preschool8. Economic growthRegression AnalysisFemaleSeasonsAdultmedicine.medical_specialtyAdolescentClimate changeHeat Stress DisordersMESH: Mediterranean Region/epidemiology03 medical and health sciencesMiddle EastYoung AdultmedicineMESH: CitiesHumansCitiesMortalityMESH: Heat Stress Disorders/mortality*0105 earth and related environmental sciencesMESH: Hot Temperature/adverse effectsAgedEstimationMESH: AdolescentMESH: Age FactorsMESH: Heat Stress Disorders/etiologyMESH: HumansPublic healthResearchMESH: Child PreschoolMESH: Time FactorsInfant NewbornUrban HealthPublic Health Environmental and Occupational HealthMESH: Africa Northern/epidemiologyInfantMESH: AdultMESH: MaleApparent temperature13. Climate actionHot temperature; Mortality; Mediterranean region; Heterogeneity; Age groups; Public Health; TIME series analysis; Older people; Public health; Unemployment statistics; Climatic changes[SDV.SPEE]Life Sciences [q-bio]/Santé publique et épidémiologieMESH: Mortality/trends*HeterogeneityAge groupsMESH: FemaleMESH: SeasonsMedicine; Geriatrics
researchProduct